
Nomura Holdings, Inc.
Financial ServicesNYSE:NMR · New York Stock Exchange
+$0.03 today
Vol 1.11M · Avg 1.78M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
9.8%
avg 5.8%
ROIC
1.6%
avg 0.6%
ROA
0.6%
avg 0.4%
Analysis
ROE is currently the strongest return metric at 9.8% versus its period average of 5.8%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Christopher Paul Willcox | Executive Officer, Deputy President, Head of Wholesale & Chairman of Investment Management | $14.28M | — | 58 | $0.00 | <0.01% |
Kentaro Okuda | President, Group Chief Executive Officer, Representative Executive Officer & Director | $7.54M | — | 63 | $0.00 | <0.01% |
Yutaka Nakajima | Representative Executive Officer, Deputy President & Director | $4.30M | — | 61 | $0.00 | <0.01% |
Toshiyasu Iiyama | Chief of Staff, Executive Officer, Head of Well Growing Institute & Deputy President | $3.19M | — | 61 | $0.00 | <0.01% |
Takumi Kitamura | Executive Officer & Chief Transformation Officer | $1.69M | — | 60 | $0.00 | <0.01% |
Sotaro Kato | Executive Officer & Chief Risk Officer | $1.42M | — | 57 | $0.00 | <0.01% |
Yosuke Inaida | Senior MD & Head of Content Company and Global Regulatory Affairs | $880,887.00 | — | 59 | — | — |
Hiroyuki Moriuchi | Executive Officer & Chief Financial Officer | — | — | 50 | $0.00 | <0.01% |
Gareth Nicholson | Executive Director, Chief Investment Officer & Head of Discretionary Portfolio Management | — | — | — | — | — |
Patrick Eltridge | Senior MD & Chief Information Officer | — | — | — | $0.00 | <0.01% |
Shinichi Mizuno | Senior MD, Joint Chief Compliance Officer & Audit Mission Director. | — | — | 58 | $0.00 | <0.01% |
Takako Mori | Senior MD of General Counsel & Joint Chief Compliance Officer | — | — | — | $0.00 | <0.01% |
Akihiro Koseki | MD, Head of Investor Relations & Co-Head of Investment Banking - Asia ex-Japan | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
3
$3,898.70
Sells
0
$0.00
Net Sentiment
+$3,898.70
Net buying
Most Active
Ishizuka Masahiro
1 transactions
| Date | Insider | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 25, 2026 | Ishizuka Masahiro Indirect | Buy | 238.186 | $8.05 | $1,917.40 | |
| Mar 25, 2026 | Ozaki Yukiko Indirect | Buy | 7.939 | $8.05 | $63.91 | |
| Mar 25, 2026 | Ogawa Shoji Indirect | Buy | 238.186 | $8.05 | $1,917.40 |
Analysis
Insiders reported 3 buys worth $3,898.70 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $3,898.70. Ishizuka Masahiro was the most active insider with 1 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +7.8% | +10.6% (14yr)1 analysts |
| Revenue | N/A | N/A | -7.7% | +2.7% (14yr)3 analysts |
| Net Income | N/A | N/A | +7.0% | +9.1% (14yr)3 analysts |
| EBIT | N/A | N/A | -11.4% | +2.5% (14yr)3 analysts |
Analysis
Recent growth has been strongest in EPS at +7.8% over three years. Forward estimates point to EPS at +10.6% (14yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector

Huntington Bancshares Incorporated
NASDAQ:HBAN
$35.53B

Credicorp Ltd.
NYSE:BAP
$29.58B

Citizens Financial Group, Inc.
NYSE:CFG
$28.45B

Regions Financial Corporation
NYSE:RF
$24.83B

KeyCorp
NYSE:KEY
$24.54B

T. Rowe Price Group, Inc.
NASDAQ:TROW
$23.47B

Loews Corporation
NYSE:L
$22.21B

Tradeweb Markets Inc.
NASDAQ:TW
$21.46B
Who manages NMR?
Nomura Holdings, Inc. (NMR) lists 13 active executives. The top listed executive is Hiroyuki Moriuchi, Executive Officer & Chief Financial Officer.
Are NMR insiders buying or selling?
Recent insider activity shows net selling of $53.96M.
Explore More
Continue the stock analysis
Jump to another research area for this company.